AKRO
Price
$29.74
Change
-$1.23 (-3.97%)
Updated
Nov 14, 04:00 PM (EDT)
119 days until earnings call
PLRX
Price
$13.08
Change
-$0.69 (-5.01%)
Updated
Nov 14, 03:33 PM (EDT)
110 days until earnings call
Ad is loading...

AKRO vs PLRX

Header iconAKRO vs PLRX Comparison
Open Charts AKRO vs PLRXBanner chart's image
Akero Therapeutics
Price$29.74
Change-$1.23 (-3.97%)
Volume$68.18K
CapitalizationN/A
Pliant Therapeutics
Price$13.08
Change-$0.69 (-5.01%)
Volume$124
CapitalizationN/A
AKRO vs PLRX Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AKRO vs. PLRX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and PLRX is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (AKRO: $30.97 vs. PLRX: $13.77)
Brand notoriety: AKRO and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 102% vs. PLRX: 63%
Market capitalization -- AKRO: $2.16B vs. PLRX: $837.95M
AKRO [@Biotechnology] is valued at $2.16B. PLRX’s [@Biotechnology] market capitalization is $837.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 3 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 3 bullish, 5 bearish.
  • PLRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а -12.22% price change this week, while PLRX (@Biotechnology) price change was -12.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +6.16%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.16B) has a higher market cap than PLRX($838M). AKRO YTD gains are higher at: 32.634 vs. PLRX (-23.965). PLRX has higher annual earnings (EBITDA): -181.41M vs. AKRO (-200.16M). AKRO has more cash in the bank: 760M vs. PLRX (437M). AKRO has less debt than PLRX: AKRO (36.3M) vs PLRX (60.2M). AKRO (0) and PLRX (0) have equivalent revenues.
AKROPLRXAKRO / PLRX
Capitalization2.16B838M258%
EBITDA-200.16M-181.41M110%
Gain YTD32.634-23.965-136%
P/E RatioN/AN/A-
Revenue00-
Total Cash760M437M174%
Total Debt36.3M60.2M60%
TECHNICAL ANALYSIS
Technical Analysis
AKROPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMAGX15.87N/A
N/A
Fidelity Magellan
HRLTX8.69-0.02
-0.23%
Hartford Real Asset R5
ECHSX14.39-0.05
-0.35%
Eaton Vance Worldwide Health Sci C
LICTX15.28-0.11
-0.71%
Lord Abbett International Equity R5
PXSGX39.03-0.35
-0.89%
Virtus KAR Small-Cap Growth I

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.36%
NTLA - PLRX
52%
Loosely correlated
-3.24%
BEAM - PLRX
50%
Loosely correlated
-1.57%
ABSI - PLRX
49%
Loosely correlated
-13.74%
PGEN - PLRX
49%
Loosely correlated
-3.57%
INZY - PLRX
48%
Loosely correlated
-5.59%
More